多动脉冠状动脉移植:桡动脉作为第二动脉移植物的生存获益
该倾向匹配观察性研究纳入4303例首次孤立CABG患者,比较多动脉移植(MAG)与常规移植的长期生存。MAG与中位生存延长及死亡风险降低相关(匹配组HR 0.75,95%CI 0.64-0.88)。在晚期再发心梗或心绞痛亚组中,MAG与对照组中位生存无显著差异。
要点
- 桡动脉作为第二动脉移植物未增加院内并发症。
- 晚期再发心梗或心绞痛患者中MAG生存获益不显著。
核心结论
- 多动脉血运重建,尤其是使用桡动脉作为第二动脉移植物,与显著的生存获益相关,且不增加院内并发症。
研究设计与样本
- 倾向匹配观察性研究,初始未匹配人群为2000至2018年间首次孤立冠状动脉旁路移植术患者4303例,匹配后1187例患者与匹配对照比较。
主要发现
- MAG与未匹配组和匹配组的中位生存延长相关,差异分别为962天和1459天(log-rank检验P=0.029和0.0004)。
- MAG与未匹配组和匹配组的死亡风险降低相关,风险比分别为0.72(95%CI 0.62-0.83;P<0.0001)和0.75(95%CI 0.64-0.88;P≤0.0001)。
- 匹配组中有利于生存的因素包括低logistic EuroSCORE、肥胖、未使用主动脉内球囊反搏、射血分数>30%、年龄50-69岁、经验丰富的外科医生手术、有无糖尿病、体外循环手术和3个远端吻合。
- 在242例晚期再发心梗或心绞痛患者队列中,MAG组和对照组的中位生存期分别为3026天(95%CI 1138-3503)和3035天(95%CI 2134-3991),log-rank P=0.217,左乳内动脉通畅性更优,但桡动脉与大隐静脉移植物之间无差异。
临床怎么用
- 在心外科临床实践中,可考虑将桡动脉作为第二动脉移植物进行多动脉血运重建,以改善长期生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Despite the 10-year results of the Arterial Revascularization Trial, the controversy regarding the survival benefit of multiarterial grafting (MAG) remains. Our goal was to present our long-term survival data in this propensity-matched observational study. METHODS: A primary unmatched population of 4303 patients with first-time isolated coronary artery bypass grafts operated on between 2000 and 2018 were included. A total of 1187 post-matched patients were compared with matched controls. Multivariate logistic regression and Cox proportional hazard analyses were undertaken to assess the contribution of MAG and other covariates to the long-term survival of unmatched and propensity-matched populations. RESULTS: MAG was associated with increased median survival in both the unmatched and the matched groups; difference: 962 and 1459 days, log-rank tests; P = 0.029 and 0.0004, respectively. MAG was associated with a reduced hazard of death in the unmatched as well as in the matched groups: hazard ratio [95% confidence interval (CI)]: 0.72 (0.62-0.83); P < 0.0001 and 0.75 (0.64-0.88); P ≤ 0.0001, respectively. In the matched group, the prosurvival factors were low logistic EuroSCORE, obesity, no intra-aortic balloon pump, an ejection fraction >30%, age 50-69 years, operation by an experienced surgeon, with and without diabetes, on-pump surgery and 3 distal anastomoses. In a cohort of 242 late-presenting patients with reinfarction or recurrent angina, both MAG and control populations were associated with reduced median survival; median (95% CI): MAG: 3026 (1138-3503); control: 3035 (2134-3991), log-rank P = 0.217 with superior patency of the left internal mammary artery but no difference between radial artery and saphenous vein grafts. CONCLUSIONS: Multiarterial revascularization, especially using the radial artery as a second arterial conduit, is associated with a significant survival benefit and a lack of in-hospital morbidity.
引用
- Qureshi SH, Boulemden A, Darwin O, et al. Multiarterial coronary grafting using the radial artery as a second arterial graft: how far does the survival benefit extend? Eur J Cardiothorac Surg. 2021. PMID: 34347054. doi:10.1093/ejcts/ezab308
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。